. Author manuscript; available in PMC: 2020 Sep 2.

Published in final edited form as: Cancer Prev Res (Phila). 2017 Nov 22;11(2):113–119. doi: 10.1158/1940-6207.CAPR-17-0245

Table 5.

Association of CLS-B with histologic impression and lobular involution

	N (%) with any CLS-B
	Overall	KTB	BBD controls	BBD cases
Histologic impression
No histologic abnormality	2/54 (3.7%)	2/54 (3.7%)	-	-
Nonproliferative disease	11/79 (13.9%)	1/22 (4.5%)	8/34 (23.5%)	2/23 (8.7%)
Proliferative disease without atypia	18/87 (20.7%)	0/7 (0%)	5/38 (13.2%)	13/42 (31.0%)
Proliferative disease with atypia	9/36 (25.0%)	0/1 (0%)	3/14 (21.4%)	6/21 (28.6%)
Lobular involution
None	2/36 (5.6%)	1/4 (25.0%)	0/12 (0%)	1/20 (5%)
Partial	22/114 (19.3%)	1/35 (2.9%)	7/37 (18.9%)	14/42 (33.3%)
Complete	14/96 (14.6%)	1/44 (2.3%)	9/36 (25.0%)	4/16 (25.0%)